Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2023-2027

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Service
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
4.2 Service Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Service
6.1 Market segments
Exhibit 30: Chart on Service - Market share 2022-2027 (%)
Exhibit 31: Data Table on Service - Market share 2022-2027 (%)
6.2 Comparison by Service
Exhibit 32: Chart on Comparison by Service
Exhibit 33: Data Table on Comparison by Service
6.3 CMO - Market size and forecast 2022-2027
Exhibit 34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on CMO - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
6.4 CRO - Market size and forecast 2022-2027
Exhibit 38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on CRO - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Service
Exhibit 42: Market opportunity by Service ($ billion)

7 Market Segmentation by End-user
7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by End-user
Exhibit 46: Data Table on Comparison by End-user
7.3 Big pharmaceuticals - Market size and forecast 2022-2027
Exhibit 47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
7.4 Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027
Exhibit 51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
7.5 Generic pharmaceuticals - Market size and forecast 2022-2027
Exhibit 55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 India - Market size and forecast 2022-2027
Exhibit 85: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on India - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Almac Group Ltd.
Exhibit 108: Almac Group Ltd. - Overview
Exhibit 109: Almac Group Ltd. - Product / Service
Exhibit 110: Almac Group Ltd. - Key offerings
12.4 Boehringer Ingelheim International GmbH
Exhibit 111: Boehringer Ingelheim International GmbH - Overview
Exhibit 112: Boehringer Ingelheim International GmbH - Business segments
Exhibit 113: Boehringer Ingelheim International GmbH - Key news
Exhibit 114: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 115: Boehringer Ingelheim International GmbH - Segment focus
12.5 Cadila Pharmaceuticals Ltd.
Exhibit 116: Cadila Pharmaceuticals Ltd. - Overview
Exhibit 117: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibit 118: Cadila Pharmaceuticals Ltd. - Key offerings
12.6 Catalent Inc.
Exhibit 119: Catalent Inc. - Overview
Exhibit 120: Catalent Inc. - Business segments
Exhibit 121: Catalent Inc. - Key news
Exhibit 122: Catalent Inc. - Key offerings
Exhibit 123: Catalent Inc. - Segment focus
12.7 Charles River Laboratories International Inc.
Exhibit 124: Charles River Laboratories International Inc. - Overview
Exhibit 125: Charles River Laboratories International Inc. - Business segments
Exhibit 126: Charles River Laboratories International Inc. - Key news
Exhibit 127: Charles River Laboratories International Inc. - Key offerings
Exhibit 128: Charles River Laboratories International Inc. - Segment focus
12.8 Cmic Holdings Co. Ltd.
Exhibit 129: Cmic Holdings Co. Ltd. - Overview
Exhibit 130: Cmic Holdings Co. Ltd. - Business segments
Exhibit 131: Cmic Holdings Co. Ltd. - Key offerings
Exhibit 132: Cmic Holdings Co. Ltd. - Segment focus
12.9 Dr Reddys Laboratories Ltd.
Exhibit 133: Dr Reddys Laboratories Ltd. - Overview
Exhibit 134: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 135: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 136: Dr Reddys Laboratories Ltd. - Segment focus
12.10 ICON plc
Exhibit 137: ICON plc - Overview
Exhibit 138: ICON plc - Product / Service
Exhibit 139: ICON plc - Key offerings
12.11 IQVIA Holdings Inc.
Exhibit 140: IQVIA Holdings Inc. - Overview
Exhibit 141: IQVIA Holdings Inc. - Business segments
Exhibit 142: IQVIA Holdings Inc. - Key news
Exhibit 143: IQVIA Holdings Inc. - Key offerings
Exhibit 144: IQVIA Holdings Inc. - Segment focus
12.12 Laboratory Corp. of America Holdings
Exhibit 145: Laboratory Corp. of America Holdings - Overview
Exhibit 146: Laboratory Corp. of America Holdings - Business segments
Exhibit 147: Laboratory Corp. of America Holdings - Key news
Exhibit 148: Laboratory Corp. of America Holdings - Key offerings
Exhibit 149: Laboratory Corp. of America Holdings - Segment focus
12.13 Lonza Group Ltd.
Exhibit 150: Lonza Group Ltd. - Overview
Exhibit 151: Lonza Group Ltd. - Business segments
Exhibit 152: Lonza Group Ltd. - Key news
Exhibit 153: Lonza Group Ltd. - Key offerings
Exhibit 154: Lonza Group Ltd. - Segment focus
12.14 Lupin Ltd.
Exhibit 155: Lupin Ltd. - Overview
Exhibit 156: Lupin Ltd. - Product / Service
Exhibit 157: Lupin Ltd. - Key news
Exhibit 158: Lupin Ltd. - Key offerings
12.15 Recipharm AB
Exhibit 159: Recipharm AB - Overview
Exhibit 160: Recipharm AB - Business segments
Exhibit 161: Recipharm AB - Key offerings
Exhibit 162: Recipharm AB - Segment focus
12.16 Samsung Electronics Co. Ltd.
Exhibit 163: Samsung Electronics Co. Ltd. - Overview
Exhibit 164: Samsung Electronics Co. Ltd. - Business segments
Exhibit 165: Samsung Electronics Co. Ltd. - Key news
Exhibit 166: Samsung Electronics Co. Ltd. - Key offerings
Exhibit 167: Samsung Electronics Co. Ltd. - Segment focus
12.17 Syneos Health Inc.
Exhibit 168: Syneos Health Inc. - Overview
Exhibit 169: Syneos Health Inc. - Business segments
Exhibit 170: Syneos Health Inc. - Key offerings
Exhibit 171: Syneos Health Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Service
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global pharmaceutical contract research and manufacturing (CRAM) market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Service Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Service - Market share 2022-2027 (%)
Exhibits 31: Data Table on Service - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Service
Exhibits 33: Data Table on Comparison by Service
Exhibits 34: Chart on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on CMO - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on CMO - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on CMO - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on CRO - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on CRO - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on CRO - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Service ($ billion)
Exhibits 43: Chart on End-user - Market share 2022-2027 (%)
Exhibits 44: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by End-user
Exhibits 46: Data Table on Comparison by End-user
Exhibits 47: Chart on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Data Table on Big pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits 49: Chart on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Big pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Data Table on Small and medium-sized pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits 53: Chart on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Small and medium-sized pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits 56: Data Table on Generic pharmaceuticals - Market size and forecast 2022-2027 ($ billion)
Exhibits 57: Chart on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Generic pharmaceuticals - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by End-user ($ billion)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits 86: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits 87: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 91: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ billion)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: Almac Group Ltd. - Overview
Exhibits 109: Almac Group Ltd. - Product / Service
Exhibits 110: Almac Group Ltd. - Key offerings
Exhibits 111: Boehringer Ingelheim International GmbH - Overview
Exhibits 112: Boehringer Ingelheim International GmbH - Business segments
Exhibits 113: Boehringer Ingelheim International GmbH - Key news
Exhibits 114: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 115: Boehringer Ingelheim International GmbH - Segment focus
Exhibits 116: Cadila Pharmaceuticals Ltd. - Overview
Exhibits 117: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits 118: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits 119: Catalent Inc. - Overview
Exhibits 120: Catalent Inc. - Business segments
Exhibits 121: Catalent Inc. - Key news
Exhibits 122: Catalent Inc. - Key offerings
Exhibits 123: Catalent Inc. - Segment focus
Exhibits 124: Charles River Laboratories International Inc. - Overview
Exhibits 125: Charles River Laboratories International Inc. - Business segments
Exhibits 126: Charles River Laboratories International Inc. - Key news
Exhibits 127: Charles River Laboratories International Inc. - Key offerings
Exhibits 128: Charles River Laboratories International Inc. - Segment focus
Exhibits 129: Cmic Holdings Co. Ltd. - Overview
Exhibits 130: Cmic Holdings Co. Ltd. - Business segments
Exhibits 131: Cmic Holdings Co. Ltd. - Key offerings
Exhibits 132: Cmic Holdings Co. Ltd. - Segment focus
Exhibits 133: Dr Reddys Laboratories Ltd. - Overview
Exhibits 134: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 135: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 136: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 137: ICON plc - Overview
Exhibits 138: ICON plc - Product / Service
Exhibits 139: ICON plc - Key offerings
Exhibits 140: IQVIA Holdings Inc. - Overview
Exhibits 141: IQVIA Holdings Inc. - Business segments
Exhibits 142: IQVIA Holdings Inc. - Key news
Exhibits 143: IQVIA Holdings Inc. - Key offerings
Exhibits 144: IQVIA Holdings Inc. - Segment focus
Exhibits 145: Laboratory Corp. of America Holdings - Overview
Exhibits 146: Laboratory Corp. of America Holdings - Business segments
Exhibits 147: Laboratory Corp. of America Holdings - Key news
Exhibits 148: Laboratory Corp. of America Holdings - Key offerings
Exhibits 149: Laboratory Corp. of America Holdings - Segment focus
Exhibits 150: Lonza Group Ltd. - Overview
Exhibits 151: Lonza Group Ltd. - Business segments
Exhibits 152: Lonza Group Ltd. - Key news
Exhibits 153: Lonza Group Ltd. - Key offerings
Exhibits 154: Lonza Group Ltd. - Segment focus
Exhibits 155: Lupin Ltd. - Overview
Exhibits 156: Lupin Ltd. - Product / Service
Exhibits 157: Lupin Ltd. - Key news
Exhibits 158: Lupin Ltd. - Key offerings
Exhibits 159: Recipharm AB - Overview
Exhibits 160: Recipharm AB - Business segments
Exhibits 161: Recipharm AB - Key offerings
Exhibits 162: Recipharm AB - Segment focus
Exhibits 163: Samsung Electronics Co. Ltd. - Overview
Exhibits 164: Samsung Electronics Co. Ltd. - Business segments
Exhibits 165: Samsung Electronics Co. Ltd. - Key news
Exhibits 166: Samsung Electronics Co. Ltd. - Key offerings
Exhibits 167: Samsung Electronics Co. Ltd. - Segment focus
Exhibits 168: Syneos Health Inc. - Overview
Exhibits 169: Syneos Health Inc. - Business segments
Exhibits 170: Syneos Health Inc. - Key offerings
Exhibits 171: Syneos Health Inc. - Segment focus
Exhibits 172: Inclusions checklist
Exhibits 173: Exclusions checklist
Exhibits 174: Currency conversion rates for US$
Exhibits 175: Research methodology
Exhibits 176: Validation techniques employed for market sizing
Exhibits 177: Information sources
Exhibits 178: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global pharmaceutical contract research and manufacturing (CRAM) market: Almac Group Ltd., Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Ltd., Catalent Inc., Charles River Laboratories International Inc., Cmic Holdings Co. Ltd., Dr Reddys Laboratories Ltd., ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, Lonza Group Ltd., Lupin Ltd., Recipharm AB, Samsung Electronics Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., PCI Pharma Services, Parexel International Corp., OPTIMAPHARM d.o.o., and Novotech Australia Pty Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing number of us FDA-approved manufacturing facilities.`

According to the report, one of the major drivers for this market is the availability of cost-efficient resources in emerging markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

• Almac Group Ltd.
• Boehringer Ingelheim International GmbH
• Cadila Pharmaceuticals Ltd.
• Catalent Inc.
• Charles River Laboratories International Inc.
• Cmic Holdings Co. Ltd.
• Dr Reddys Laboratories Ltd.
• ICON plc
• IQVIA Holdings Inc.
• Laboratory Corp. of America Holdings
• Lonza Group Ltd.
• Lupin Ltd.
• Recipharm AB
• Samsung Electronics Co. Ltd.
• Syneos Health Inc.
• Thermo Fisher Scientific Inc.
• PCI Pharma Services
• Parexel International Corp.
• OPTIMAPHARM d.o.o.
• Novotech Australia Pty Ltd.